Workshop

Evonik, Knauer & Spectradyne LNP Innovation Workshop

April 9, 2026​ | Cambridge, MA, USA


Overview

Are you ready to explore recent advancements and unlock the future of nanomedicine and gene therapy? We invite you to join us for an exclusive workshop, co-hosted by Evonik, Knauer, and Spectradyne, designed to provide valuable insights into navigating the complexities of LNP development, addressing scale-up challenges, and exploring novel lipids to fully realize the potential of RNA therapeutics.

Why attend?

This is not just another workshop; it's a unique opportunity to engage with thought leaders from academia and industry while experiencing firsthand the latest innovations in LNP technology.


Key learnings for participants

  • Cutting-Edge Insights: Delve into topics such as AI in gene therapy, stable RNA delivery, and the latest advancements in LNP mixing technology and analytical techniques.
  • Hands-On Experience: Participate in a live lab demonstration of Knauer’s IJM NanoScaler Pro mixer and Spectradyne's ARC particle analyzer, providing practical insights into state-of-the-art technology.
  • Networking Opportunities: Connect with peers, industry leaders, and innovators in a collaborative environment designed for meaningful exchanges and future partnerships
  • Engaging Panel Discussion: Join our experts as they tackle pressing industry challenges and share insights on overcoming scale-up hurdles in LNP formulations.





Note: Please fill in your details and click 'Submit' to register for the workshop. Once we have received your registration, we will send you a status notification as soon as possible. Due to the high demand for our workshops, we sometimes need to reject registrations or put you on a waiting list. Workshop materials will be available for download at the end of the workshop. Any photographs taken during the event are the property of Evonik and may be used for promotional purposes.



Details
Participation fee: Free of charge 
Workshop language: English



Agenda
The workshop will start at 9:00 a.m. on Thursday, April 9, 2026, and finish at 4:00 p.m. on the same day. To see the detailed workshop program please click here.



Venue
The workshop will take place at:
238 Main Street, Cambridge, MA
(located at Kendall/M.I.T. MBTA stop)
USA

Fill out the form to register for the workshop:

Agenda

09:00 am - 09:30 am | Registration & Light Breakfast

09:30 am - 09:45 am | Introduction to Evonik Health Care
Andrea Engel & Cody Yetter
Evonik Health Care

09:45 am - 10:15 am | Insights into Lipid Nanoparticle Bleb Morphology and Function
Cedric Devos
M.I.T.

10:15 am - 10:45 am | Guest Speaker
TBD

10:45 am - 11:15 am | Next-Gen LNP Mixing Technology
Svea Stephan
Knauer

11:15 am - 11:45 am | Roundtable

11:45 am - 12:45 pm | Lunch & Networking

12:45 pm - 01:15 pm | Scale up challenges in LNP Drug Product Development
Michael Parr
Evonik Health Care

01:15 pm - 01:45 pm | Unlocking Programmable Drug Delivery with an AI-powered LNP Design Platform
TBD

01:45 pm - 02:15 pm | Advanced Analytical Techniques for LNP Characterization
Jean-Luc Fraikin
Spectradyne

02:15 pm - 02:30 pm | Panel Discussion and Wrap-up

02:30 pm | Light Refreshments and Networking
Lab tour and Demo on Knauer’s IJM NanoScaler Pro and Spectradyne’s ARC particle analyzer

04:00 pm | End of Workshop





Disclaimer

Notice for business transactions
We assume that you are not currently or foreseeably involved in a business decision in favour of or in direct connection with the Evonik Group or, if this is the case, the decision will not be influenced by this invitation. Therefore, we do not see any concerns on our part regarding your participation. However, we would like to ask you to ensure that you are allowed to accept the invitation in accordance with the regulations that apply to you.

Note for public officials
We assume that you are not or have not been involved in any official act in favour of or in connection with the Evonik Group, either now or in the foreseeable future or in the past and therefore your participation in the event is not subject to any concerns. In addition, we ask you to ensure that your superior approves your participation or you may also accept the invitation in accordance with the rules applicable to you. By registering or participating, you confirm to us that the acceptance of this invitation is permitted according to your internal rules and that you have obtained all necessary approvals. If this is not the case, we ask you for a corresponding note.

Tax notices
Any tax liability resulting from this event will be borne by Evonik Industries AG through a flat-rate tax levy pursuant to Section 37b of the German Income Tax Act (EStG). If you are not taxable in Germany, please clarify whether you must report the invitation to your employer for taxation or whether taxation must be made via your income tax return.




QUESTIONS? 

Likhitha Bingham
Marketing Analyst
+1 256-783-9347

Cléa Michel

Cléa Michel is product manager for Cell Culture Ingredients at Evonik Health Care. She provides biopharma companies and media manufacturers with the finest specialty ingredients to increase cell culture performance. Cléa has a background in biochemistry and biotechnology engineering and holds a master’s degree from the National Institute of Applied Sciences in Lyon, France. She has held various positions in marketing, project management and business development and is passionate about innovative solutions that enable the successful development of life-saving biopharmaceuticals.
Dr. Stephan Brinkmann

Stephan Brinkmann works as project manager and head of Evonik's Biopharma Applications group at Evonik R&D for the Health Care business line. He is responsible for biopharma innovation projects as well as application tests of Evonik's cell culture ingredients (i.e., cQrex® peptides). Stephan studied molecular biotechnology at Bielefeld University in Germany, where he specialized in biopharma upstream and downstream process development. Before joining Evonik, Stephan worked in Switzerland on industrial mammalian cell line development for the production of therapeutic biologics. Stephan obtained his Ph.D. in a public private partnership with Sanofi and later Evotec at Fraunhofer IME in Giessen with a focus on the discovery of natural products, especially peptides.

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register